Both Lauder and de la Faverie will report to Lynne Greene, group president of Clinique, Origins, Ojon, Aveda and Darphin. As announced in 2012. Greene was promoted to group president as part of an organizational redesign to further align brands and provide high potential leaders with increased opportunities.
“Lynne’s vision combined with her industry-leading creativity has propelled Clinique’s exceptional global results and her close partnership with Jane will enable Clinique’s future success. Jane’s new role reflects her proven talent as one of our Company’s valued business leaders and innovative thinkers. Her ability to take brands and help maximize their global potential has been a key driver in our Company’s success,” said Fabrizio Freda, president and chief executive officer, The Estée Lauder Companies.
In addition to supporting the company’s organizational evolution, this appointment was a natural move for Lauder who earlier in her career was senior vice president, global marketing for Clinique where she was responsible for the brand’s overall strategic marketing and helped take the brand into new markets. As a result of her success in this role, Lauder later became global brand president, Origins, Ojon and Darphin.
De la Faverie joined The Estée Lauder Companies in 2011 as senior vice president, global general manager, Aramis and Designer Fragrances; shortly thereafter Lab Series and GoodSkin Labs were added to his responsibilities.